Valuation: PeptiDream Inc.

Market Cap 129B 809M 698M 655M 597M 1.12B 77.34B 1.14B 7.68B 3.01B 38.75B 3.04B 2.97B P/E 2026 *
10.1x
P/E 2027 * 10.2x
Enterprise Value 99.22B 623M 538M 504M 459M 864M 59.54B 876M 5.91B 2.32B 29.83B 2.34B 2.29B EV / Sales 2026 *
2.22x
EV / Sales 2027 * 1.93x
Free-Float
72.4%
Yield 2026 *
-
Yield 2027 * 0.6%
1 day-2.81%
1 week+1.64%
Current month+5.84%
1 month+2.40%
3 months-11.05%
6 months-36.09%
Current year-39.48%
1 week 972.5
Extreme 972.5
1,073
1 month 906.4
Extreme 906.4
1,073
Current year 906.4
Extreme 906.4
1,788
1 year 906.4
Extreme 906.4
1,818.5
3 years 906.4
Extreme 906.4
3,060
5 years 906.4
Extreme 906.4
4,140
10 years 906.4
Extreme 906.4
6,540
Manager TitleAgeSince
Chief Executive Officer 51 31/12/2021
Chief Operating Officer - 01/07/2026
Chief Tech/Sci/R&D Officer - 31/03/2024
Director TitleAgeSince
Director/Board Member 51 31/07/2008
Director/Board Member 51 31/08/2017
Director/Board Member 55 28/02/2021
Change 5-day change 1-year change 3-year change Capi.($)
-2.81%+1.64%-38.48%-44.44% 833M
+4.80%+7.80%+70.64%+114.21% 70.07B
+17.12%+11.50%+49.15%+87.30% 52.87B
+3.00%-5.40%+0.16%+480.20% 27.02B
+2.26%+0.65%+49.19%+10.30% 23.61B
-1.67%-1.20%-18.53%-19.02% 23.38B
-6.00%+13.71%+244.39%+443.26% 19.43B
+3.80%+5.62%+39.57%-15.26% 18.75B
+0.38%-3.15%+20.39%+589.77% 15.85B
+2.00%-1.18%+38.60%+149.21% 12.7B
Average +2.30%-1.41%+45.51%+179.55% 26.45B
Weighted average by Cap. +5.00%-1.13%+55.01%+169.84%

Financials

2026 *2027 *
Net sales 44.69B 280M 242M 227M 207M 389M 26.82B 394M 2.66B 1.04B 13.44B 1.05B 1.03B 46.08B 289M 250M 234M 213M 401M 27.65B 407M 2.75B 1.08B 13.85B 1.09B 1.06B
Net income 12.87B 80.76M 69.72M 65.41M 59.57M 112M 7.72B 114M 767M 300M 3.87B 303M 297M 12.69B 79.65M 68.77M 64.51M 58.76M 110M 7.62B 112M 756M 296M 3.82B 299M 293M
Net Debt -29.66B -186M -161M -151M -137M -258M -17.8B -262M -1.77B -693M -8.92B -699M -684M -39.87B -250M -216M -203M -185M -347M -23.92B -352M -2.38B -931M -11.99B -939M -919M
Logo PeptiDream Inc.
PeptiDream Inc. is a Japan-based bio-venture company started by the University of Tokyo and principally engaged in the discovery and development of non-standard peptide therapeutics. The Company operates the Peptide Discovery Platform System (PDPS), a drug development platform system and conducts research and development (R&D) on new drug candidates based on the joint R&D with pharmaceutical companies in Japan and overseas. The Company is involved in the business centered on drug development based on special peptides. The Company's businesses include drug discovery joint R&D, PDPS technology loan (PDPS technology license) and expansion of its own pipeline through strategic alliance (strategic alliance or in-house drug discovery).
Employees
763
Date Price Change Volume
17/08/26 JP¥1,002.50 -2.81% 1,431,900
14/08/26 JP¥1,031.50 -1.39% 1,484,800
13/08/26 JP¥1,046.00 +3.87% 2,206,800
12/08/26 JP¥1,007.00 +1.49% 921,200
10/08/26 JP¥992.20 +0.60% 869,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
1,002.50JPY
Average target price
2,725.00JPY
Spread / Average Target
+171.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4587 Stock